Allergic rhinitis and asthma: the nose and the airways

Key points

  • Allergic rhinitis (hay fever and its year-round forms) affects the nose. Guideline groups discuss it together with asthma because the two often need to be considered together.
  • The ARIA 2016 guideline states that allergic rhinitis affects 10 to 40 percent of the population, with real costs to quality of life, school, and work.
  • Treatment choices belong to a clinician. Guidelines compare several medicine classes and stress individual considerations.
  • Treating the nose does not automatically control asthma, and the reverse is also true.

What allergic rhinitis is

Allergic rhinitis is inflammation of the lining of the nose driven by an allergen. It is what many people call hay fever when it follows the pollen season, and it can also occur through the year when the allergen is present indoors. Typical symptoms are sneezing, a runny or blocked nose, and itchy eyes. Wheeze, chest tightness, and breathlessness are not rhinitis symptoms. They may point to asthma or another condition and need a clinician's assessment, urgently if breathing is difficult.

The allergens that provoke rhinitis overlap with those that can trigger asthma, such as pollen, house dust mites, molds, and animal fur. The pages in the allergens section explain what is known about pollen, dust mites, mold, and animals, including how limited the evidence is for avoidance measures.

Why guidelines discuss rhinitis and asthma together

The main international guideline family on this topic is called Allergic Rhinitis and its Impact on Asthma (ARIA), and the name reflects the link between nose and lungs. This page does not quote rates of people who have both conditions, because the sources reviewed here do not give them. What can be said is that a person who has asthma and nasal symptoms should mention both to their clinician, so that treatment plans are coordinated and neither is overlooked.

Nasal problems can also arise from work exposures. In France, the table of occupational diseases RG 66 is titled "rhinites et asthmes professionnels", covering both conditions in one table.1 Under that table, rhinitis qualifies when it recurs on renewed exposure or is confirmed by testing, for listed kinds of work that include handling animals and working with flour.1 The page on sensitizers and irritants at work explains how workplace exposures can affect the nose and the lungs.

How common and how costly

The 2016 revision of the ARIA guidelines states that allergic rhinitis affects 10 to 40 percent of the population. It reduces quality of life and school and work performance and is a frequent reason for consulting a family doctor. The authors add that avoidable costs from lost work productivity are even larger than those of asthma.2 These figures are estimates drawn from a guideline introduction, and they will differ by country and by how rhinitis is defined, so they should be read as an order of magnitude, not a precise rate. Hay fever is often dismissed as a nuisance, but the guideline's emphasis on quality of life, school, and work performance is a reminder that nasal symptoms are worth addressing properly, with a clinician's help.

How treatment choices are framed

The ARIA 2016 revision addresses the relative merits of oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists, used alone or in combination. The panel provides recommendations for the choice of treatment, with the rationale and with individual considerations that clinicians and patients might want to review together.2

Keeping a simple symptom record is a practical step whichever tool you use. A later "next-generation" ARIA guideline combined existing GRADE-based guidelines with real-world evidence collected through mobile technology and with allergen chamber studies, in order to refine an algorithm known as MACVIA that is used to step treatment up or down.3 This page does not describe doses, products, or when to change treatment. Those decisions depend on the person's symptoms, other conditions, and preferences, and they belong with a clinician. Do not start, stop, or change any medicine on the basis of a general web page.

What to bring to a consultation

  • A short list of the symptoms in your nose, eyes, and chest, and when they occur (season, place, activities).
  • Whether symptoms appear at work, at home, or around animals.
  • What you have already used for the nose and whether it helped, without changing anything before you speak with the clinician.
  • Questions about whether testing for specific allergens would change the plan.

The page of questions to bring to your clinician can help structure the visit.

See asthma triggers, the overview of asthma and allergies in children, and the food allergy page for another allergic condition that sometimes occurs alongside asthma.

Sources

  1. INRS. Tableau RG 66: rhinites et asthmes professionnels.
  2. Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958. PubMed 28602936. DOI
  3. Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. PubMed 31627910. DOI

AsmaNet publishes educational information that does not replace advice from a doctor or occupational health professional. If someone is struggling to breathe, call your local emergency number. This content has not been reviewed by a clinician.